Walter Reed Wins FDA Clearance for 3D-Printed Titanium Cranial Plate

A Military Hospital Now Holds the Clearance Itself

The FDA granted premarket clearance to a 3D printed titanium cranial plate developed at Walter Reed National Military Medical Center. This is the first time the agency has cleared an implant produced by a point-of-care institution, meaning the hospital owns the approval rather than borrowing it from a manufacturer.

The 510(k) clearance covers the 3D MAC Titanium Cranial Plate System, designed by Dr. Peter Liacouras at the 3D Medical Application Center. The system uses 3D Systems' additive manufacturing expertise to produce patient-specific implants directly at the hospital.

Why This Changes the Regulatory Model

Previous point-of-care 3D printed implants carried clearance under the vendor's name. University Hospital Basel used 3D Systems' VSP workflow under MDR rules. 3D Systems itself held the approval. Walter Reed flips that arrangement. 3D MAC is the regulated manufacturer of record, and the clearance travels with the design and process to other approved military treatment facilities.

3D Systems supported the effort through design optimization, process validation, and the regulatory submission. Natalie Byrnes, 3D Systems' manager of product development for patient-specific medical technology, said the result validates combining clinical innovation with additive manufacturing and regulatory expertise.

What It Means for Wounded Service Members

U.S. Army Lt. Col. Andrea Mountney, deputy director of the DHA's Office of Regulatory Activities, said the approval speeds up access to custom hardware. Personalized patient-unique implants at the point-of-care should accelerate casualty treatment, sharpen surgical outcomes, and speed recovery. Additive manufacturing puts the capability directly into the hands of military providers.

The clearance does not stay locked at Walter Reed. Other military hospitals can adopt the same system under the existing approval, expanding access without separate regulatory submissions for each site.

Context: Other Point-of-Care Programs

Ricoh USA's 3D for Healthcare Innovation Studio lets clinicians design and print FDA-cleared anatomic models on-site. 3D LifePrints, now operating as Insight Surgery, markets its EmbedMed platform to hospitals building their own point-of-care operations. None of these programs has yet put an implant through clearance under the treating institution's own name.

Walter Reed's result breaks that barrier. A hospital lab can own FDA clearance outright instead of operating within a vendor's workflow. That distinction matters as more institutions evaluate on-site additive manufacturing for implants, surgical guides, and patient-specific devices.